Ontology highlight
ABSTRACT: Implications
These vulnerabilities may be exploited with mechanistically novel treatments, such as those targeting OXPHOS alone or possibly in combination with existing therapies. In addition, our findings underscore the impact of the tumor microenvironment in reprogramming prostate cancer metabolism.
SUBMITTER: Mossa F
PROVIDER: S-EPMC9812897 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
Mossa Federica F Robesti Daniele D Sumankalai Ramachandran R Corey Eva E Titus Mark M Kang Yuqi Y Zhang Jianhua J Briganti Alberto A Montorsi Francesco F Vellano Christopher P CP Marszalek Joseph R JR Frigo Daniel E DE Logothetis Christopher J CJ Gujral Taranjit S TS Dondossola Eleonora E
Molecular cancer research : MCR 20230101 1
Aberrant metabolic functions play a crucial role in prostate cancer progression and lethality. Currently, limited knowledge is available on subtype-specific metabolic features and their implications for treatment. We therefore investigated the metabolic determinants of the two major subtypes of castration-resistant prostate cancer [androgen receptor-expressing prostate cancer (ARPC) and aggressive variant prostate cancer (AVPC)]. Transcriptomic analyses revealed enrichment of gene sets involved ...[more]